Dec 02, 2024
Foundation Announces 2024 Grant Recipients
The Doctors Company Foundation awarded three new grants in 2024.
From
The Doctor’s Advocate
Search
Professional Education
Module 6: Controlled Substance Utilization Review and Evaluation System (CURES) (Innovations and Smart Approaches in Safe Prescribing)
This program reviews the CURES electronic database for Schedule II, III, IV, V controlled substance prescriptions dispensed in California, including time requirements involved when dispensing information needs to be reported (a controlled substance is released to the patient or patient's representative). This module will examine how non-DEA licensed physicians and surgeon practitioners can access CURES data. This module consists of four audio-filled videos. To successfully complete this course, you need to achieve a passing score of 80 percent in the post-test questions.
Obstetrics and Gynecology: Frequently Asked Patient Safety Questions
Our experts answer questions about topics in obstetrics and gynecology, including cesarean delivery on maternal request and screening mammograms.
The Doctors Company Assists Members Impacted by Hurricane Helene
Due to disruption to member medical practices from Hurricane Helene and consistent with direction from state insurance regulation offices, The Doctors Company will adjust policy cancellation and premium installment due dates for affected members. Premium due dates have generally been extended in Florida, Georgia, North Carolina, South Carolina, and Tennessee, with Florida extending from September 26, 2024, to November 26, 2024.
March 01, 2024, Healthcare Risk Management
AI Creates Liability Risks for Healthcare Organizations
Sue Boisvert, BSN, MHSA, CPPS, CPHRM, DFASHRM, Senior Patient Safety Risk Manager, Department of Patient Safety and Risk Management, The Doctors Company, part of TDC Group, discusses how artificial intelligence (AI) is becoming more common in healthcare, and while it offers substantial benefits, there are serious risks to consider.
Oct 26, 2023
Guided Risk Self-Assessment Exclusively for Member Practices
The Guided Risk Self-Assessment contains risk mitigation strategies to assist healthcare professionals in medical or dental offices. This program will help practitioners and their staff develop a comprehensive understanding of practice risks and learn specific actions to prevent patient injuries and professional liability claims.
Professional Education
Anesthesia: Diagnosis and Management of Posterior Anterior Neck Hematoma
Anterior neck hematoma (ANH) is a serious emergency that can block the airway and endanger the life of a patient who has had neck surgery. Anesthesia professionals need to be ready to identify ANH and act when there is no surgeon nearby. This course covers recognizing the signs and symptoms of postoperative ANH and strategies for response.
The Doctors Company Receives Datos Insights 2025 Impact Award for Insurance Innovation
The Doctors Company, the nation’s largest physician-owned medical malpractice insurer, part of TDC Group, announced today that it has received a 2025 Datos Insights Impact Award for Insurance Innovation. The awards program recognizes organizations that demonstrate excellence in implementing innovative technology solutions that drive measurable business results and industry leadership.
Sep 05, 2025
An Updated Approach to Perioperative Management of Patients Undergoing Noncardiac Surgery: Cleared for Take-Off?
The new guideline for evaluating surgical patients for cardiovascular risk promotes a multidisciplinary approach that can help improve patient outcomes.
From
The Doctor’s Advocate
December 15, 2023, Inside Medical Liability
MPL Cases: What Are the Primary Drivers of High-Indemnity Medical Malpractice Claims?
Jacqueline Ross, RN, PhD, Coding Director, and Kathrine Soulsby, RN, BSN, Senior Patient Safety Analyst, The Doctors Company, part of TDC Group, investigate high-dollar medical malpractice litigation and explain how reducing diagnostic errors is paramount to enhancing patient safety and mitigating loss costs.